Peter Hillemanns Selected Research

5-aminolevulinic acid hexyl ester

1/2022	Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol.
3/2017	Sensitization of immune cells following hexylaminolevulinate photodynamic therapy of cervical intraepithelial neoplasia.
4/2015	A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.
2/2015	Topical hexaminolevulinate photodynamic therapy for the treatment of persistent human papilloma virus infections and cervical intraepithelial neoplasia.
8/2014	Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia.
8/2012	Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate--a double-blind, dose-finding study.
9/2011	Treatment of high grade cervical intraepithelial neoplasia by photodynamic therapy using hexylaminolevulinate may be costeffective compared to conisation procedures due to decreased pregnancy-related morbidity.
11/2008	Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate.
3/2008	Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Hillemanns Research Topics

Disease

50	Neoplasms (Cancer) 01/2022 - 01/2002
36	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2002
23	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2002
22	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022 - 01/2002
14	Uterine Cervical Dysplasia 02/2019 - 01/2004
7	Ovarian Epithelial Carcinoma 01/2018 - 05/2014
6	Vulvar Neoplasms (Vulvar Cancer) 01/2022 - 03/2015
6	Carcinoma (Carcinomatosis) 10/2021 - 02/2006
6	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 01/2002
6	Infections 01/2021 - 11/2008
6	Aneuploidy (Aneuploid) 02/2012 - 01/2002
4	Neoplasm Metastasis (Metastasis) 02/2022 - 09/2007
4	Papillomavirus Infections 10/2021 - 11/2008
3	Pain (Aches) 10/2020 - 04/2004
3	Familial Breast Cancer 01/2017 - 11/2010
3	Cicatrix (Scar) 06/2015 - 08/2002
3	Condylomata Acuminata (Genital Wart) 06/2008 - 09/2007
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022 - 10/2021
2	Obesity 01/2021 - 11/2015
2	Endometriosis 01/2020 - 01/2018
2	Genetic Risk Score 01/2020 - 05/2015
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 01/2017
2	Triple Negative Breast Neoplasms 01/2019 - 01/2016
2	Wounds and Injuries (Trauma) 01/2018 - 04/2004
2	Genomic Instability 01/2017 - 01/2016
2	Fibrosis (Cirrhosis) 01/2016 - 11/2010
2	Hypercalcemia (Milk Alkali Syndrome) 08/2014 - 08/2012
1	Squamous Intraepithelial Lesions 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021

Drug/Important Bio-Agent (IBA)

19	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 01/2002
14	Estrogen ReceptorsIBA 01/2020 - 07/2009
9	5-aminolevulinic acid hexyl ester FDA Link 01/2022 - 03/2008
9	Biological ProductsIBA 10/2021 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2008
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2017 - 01/2008
5	Hormones (Hormone)IBA 10/2021 - 02/2011
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 02/2011
5	Messenger RNA (mRNA)IBA 01/2018 - 05/2007
4	PlatinumIBA 12/2021 - 02/2016
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2012
4	AcidsIBA 01/2017 - 01/2004
4	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 02/2012 - 06/2007
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2015
3	VaccinesIBA 01/2016 - 01/2011
3	Nonsense Codon (Nonsense Mutation)IBA 03/2015 - 11/2009
3	PorphyrinsIBA 03/2008 - 01/2004
3	Fluorescein-5-isothiocyanate (FITC)IBA 01/2002 - 01/2002
3	Keratins (Keratin)IBA 01/2002 - 01/2002
2	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 10/2017
2	Chimeric Antigen ReceptorsIBA 09/2021 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2016
2	human ERBB2 proteinIBA 01/2020 - 12/2011
2	A-Form DNA (A-DNA)IBA 01/2019 - 01/2017
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2018 - 01/2017
2	GSK 1363089IBA 12/2016 - 10/2015
2	Pharmaceutical PreparationsIBA 12/2016 - 02/2011
2	Carboplatin (JM8)FDA LinkGeneric 12/2015 - 02/2011
2	Small Interfering RNA (siRNA)IBA 10/2015 - 06/2014
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 02/2012 - 02/2012
2	CK 17IBA 01/2002 - 01/2002
1	Codon (Codons)IBA 09/2021
1	HDL LipoproteinsIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	LipidsIBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Sertraline (Zoloft)FDA LinkGeneric 01/2021
1	Citalopram FDA LinkGeneric 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	CholesterolIBA 01/2021
1	Ribonucleases (Ribonuclease)IBA 12/2020
1	micaIBA 11/2020
1	HLA-DQA1 antigen (HLA DQA1)IBA 11/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 08/2020

Therapy/Procedure

18	Therapeutics 02/2022 - 01/2002
13	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 11/2006
11	Drug Therapy (Chemotherapy) 02/2022 - 01/2002
11	Photochemotherapy (Photodynamic Therapy) 01/2022 - 02/2006
8	Hysterectomy 01/2022 - 01/2017
4	Radiotherapy 02/2022 - 03/2015
3	Brachytherapy 02/2022 - 01/2013
3	Cytoreduction Surgical Procedures 12/2021 - 12/2015
3	Cesarean Section (Caesarean Section) 06/2015 - 08/2003
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2022 - 02/2022
2	Mastectomy (Mammectomy) 01/2022 - 07/2010
2	Adjuvant Radiotherapy 01/2022 - 03/2015
2	Uterine Myomectomy 01/2017 - 08/2002
2	Laser Therapy (Surgery, Laser) 02/2016 - 02/2006
2	Segmental Mastectomy (Lumpectomy) 01/2016 - 01/2014
2	Endometrial Ablation Techniques 11/2015 - 01/2008
1	Palliative Care (Palliative Therapy) 02/2022
1	Self-Testing 10/2021
1	Minimally Invasive Surgical Procedures 08/2021
1	Operative Surgical Procedures 08/2020